New interim CFO in Biotie
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 1 September 2011 at 1
p.m.
New interim CFO in Biotie
Biotie's interim Chief Financial Officer Ulla Sjöblom will be leaving the
company to pursue other interests. Zack McNealy, Vice President, Finance of the
group's US subsidiary will assume the role of acting Chief Financial Officer
starting September 1, 2011. The Company expects to conclude the ongoing CFO
search process by the end of this year.
Zack McNealy has been Vice President, Finance of Biotie Therapies, Inc.
(formerly Synosia Therapeutics) since 2007. Before this, he served as a Plant
Controller, Finance Manager, and Financial Analyst with Johnson & Johnson from
1997-2006.
Turku, 1 September 2011
Biotie Therapies Corp.
Timo Veromaa
President and CEO
For further information, please contact:
Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail: virve.nurmi(at)biotie.com
DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotie Therapies Oyj via Thomson Reuters ONE
[HUG#1543410]
Unternehmensinformation / Kurzprofil:
Datum: 01.09.2011 - 12:00 Uhr
Sprache: Deutsch
News-ID 61624
Anzahl Zeichen: 1750
contact information:
Town:
Turku
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 174 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"New interim CFO in Biotie"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
